Barriers to treatment access for chronic hepatitis C virus infection: A case series

Alexander J. Millman, Boatemaa Ntiri-Reid, Risha Irvin, Maggie H. Kaufmann, Andrew Aronsohn, Jeffrey S. Duchin, John D. Scott, Claudia Vellozzi

Research output: Contribution to journalArticlepeer-review

Abstract

Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

Original languageEnglish (US)
Pages (from-to)110-113
Number of pages4
JournalTopics in antiviral medicine
Volume25
Issue number3
StatePublished - 2017

Keywords

  • HCV
  • Hepatitis C virus
  • Insurance
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases
  • Virology

Fingerprint Dive into the research topics of 'Barriers to treatment access for chronic hepatitis C virus infection: A case series'. Together they form a unique fingerprint.

Cite this